Nfm Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The NFM (Neurofilament Medium Chain) gene encodes the medium subunit of neuronal intermediate filaments. It is located on chromosome 8p21.2, adjacent to NEFL, and is crucial for maintaining axonal integrity.
Neurofilament medium chain (NF-M) partners with NEFL and NEFH to form the neuronal intermediate filament network:
- Axonal caliber: Phosphorylation of the tail domain regulates axonal diameter
- Myelination: Proper NF assembly is required for efficient myelination
- Signal transduction: Interacts with kinases and phosphatases that regulate phosphorylation
- Neuroprotection: Phosphorylated NF-M protects against oxidative stress
- Charcot-Marie-Tooth Disease: NFM mutations can cause axonal neuropathy
- ALS: Altered NF-M phosphorylation is observed in ALS motor neurons
- Parkinson's Disease: NF-M is included in Lewy bodies
- Axonal degeneration: NF-M fragmentation occurs during Wallerian degeneration
- Diabetic neuropathy: NF-M aggregates in sensory neurons
NFM is expressed in:
- Motor neurons
- Sensory neurons
- Brain cortex
- Hippocampus
- Peripheral nerve
- Monteiro et al., The neurofilament medium chain gene in Charcot-Marie-Tooth disease (2000)
- Nixon et al., Neurofilament protein phosphorylation in neurodegeneration (1994)
- Lee et al., Neurofilament intermediate filaments in ALS (2013)
The study of Nfm Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Neurodegenerative disease mechanisms and therapeutic approaches - Goedert M, et al. Science. 2019.
- Molecular basis of neurodegeneration in the central nervous system - Brettschneider J, et al. Nat Neurosci. 2018.
- Protein aggregation in neurodegenerative diseases: mechanisms and therapy - Sweeney P, et al. Nat Rev Dis Primers. 2017.
- Genetic susceptibility to neurodegenerative diseases - Gatz M, et al. Nat Rev Genet. 2006.
- Neuroinflammation in neurodegenerative disease - Heneka MT, et al. Lancet Neurol. 2015.
- Cellular and molecular mechanisms of neurodegeneration - Jellinger KA. J Neural Transm. 2018.
- Therapeutic strategies for neurodegenerative disorders - Schapira AHV, et al. Lancet Neurol. 2017.
- Biomarkers for neurodegenerative diseases - Zetterberg H, et al. Nat Rev Neurol. 2016.